SHADI ARAMESH: Open Payments
NPI 1326487091 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 9 payments from 6 companies in 2025. Trend: 2023 $108 · 2024 $491 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 3 | $174 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Alkermes, Inc. | 1 | $122 |
| Biogen, Inc. | 1 | $120 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Neos Therapeutics, LP | 1 | $14 |
Products named: AUSTEDO XR, Qelbree, ARISTADA, SKYCLARYS, Jornay PM, Adzenys XR-ODT.
Industry payments across CA — which companies pay providers there.
